NYSE:NVS - Novartis SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$93.30 -0.12 (-0.13 %)
(As of 03/25/2019 11:38 AM ET)
Previous Close$93.42
Today's Range$93.11 - $93.66
52-Week Range$72.30 - $93.89
Volume499,862 shs
Average Volume1.96 million shs
Market Capitalization$215.52 billion
P/E Ratio18.33
Dividend Yield1.97%
Beta0.67

SEC Filings

Novartis (NYSE:NVS) SEC Filings

DateFilerForm TypeView
03/22/2019
7:20 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/15/2019
4:25 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
6:56 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/26/2019
5:00 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2019
3:02 PM
Intellia Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
01/30/2019
7:09 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/30/2019
6:31 AM
Novartis (Filer)
Form IRANNOTICE
View Filing
01/30/2019
6:31 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/30/2019
6:19 AM
Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
12/21/2018
9:04 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/20/2018
11:41 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/06/2018
4:00 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
View Filing
11/05/2018
3:49 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
View Filing
10/18/2018
4:17 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
View Filing
10/18/2018
4:01 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
View Filing
10/18/2018
4:00 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
View Filing
10/18/2018
4:00 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
View Filing
10/18/2018
10:42 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/18/2018
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/04/2018
3:06 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/14/2018
8:14 AM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/06/2018
6:01 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/29/2018
7:13 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/23/2018
10:01 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/22/2018
3:34 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/22/2018
3:07 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/20/2018
4:12 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/16/2018
3:18 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
4:05 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
5:44 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/10/2018
3:29 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:21 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/06/2018
3:22 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/02/2018
3:33 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/31/2018
3:16 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/27/2018
3:21 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/27/2018
9:17 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/25/2018
3:35 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/18/2018
3:17 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/18/2018
10:54 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/29/2018
8:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/29/2018
6:27 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/19/2018
4:03 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
4:11 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/01/2018
9:03 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/01/2018
8:38 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/31/2018
8:39 AM
Novartis (Filer)
Form SD
Specialized Disclosure Report  
View Filing
05/18/2018
8:33 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/17/2018
3:07 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/16/2018
10:57 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/15/2018
11:50 AM
AveXis, Inc. (Issuer)
Novartis (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
05/15/2018
6:01 AM
AveXis, Inc. (Subject)
Novartis (Filed by)
Form SC TO-T/A
View Filing
05/14/2018
3:01 PM
Aeglea BioTherapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:28 PM
Aeglea BioTherapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2018
3:01 PM
Aeglea BioTherapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/03/2018
7:20 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/01/2018
7:46 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/01/2018
6:02 AM
AveXis, Inc. (Subject)
Novartis (Filed by)
Form SC TO-T/A
View Filing
04/23/2018
3:43 PM
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Surface Oncology, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/19/2018
9:17 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/19/2018
6:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/18/2018
4:22 PM
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Surface Oncology, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/18/2018
3:56 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/17/2018
3:27 PM
AveXis, Inc. (Subject)
Novartis (Filed by)
Form SC TO-T
View Filing
04/17/2018
8:53 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/10/2018
3:48 PM
AveXis, Inc. (Subject)
Novartis (Filed by)
Form SC TO-C
View Filing
04/09/2018
4:30 PM
AveXis, Inc. (Subject)
Novartis (Filed by)
Form SC TO-C
View Filing
04/09/2018
12:52 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/27/2018
5:25 PM
Homology Medicines, Inc. (Issuer)
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/27/2018
8:03 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/23/2018
4:29 PM
Intellia Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/19/2018
3:06 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2018
8:37 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/15/2018
3:34 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
3:19 PM
Novartis (Filed by)
resTORbio, Inc. (Subject)
Form SC 13G
View Filing
02/09/2018
7:04 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/01/2018
3:22 PM
Advanced Accelerator Applications S.A. (Subject)
Novartis (Filed by)
Form SC TO-T/A
View Filing
02/01/2018
3:22 PM
Advanced Accelerator Applications S.A. (Subject)
Novartis (Filed by)
Form SC 13D
View Filing
01/26/2018
2:53 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/24/2018
12:13 PM
Novartis (Filer)
Form IRANNOTICE
View Filing
01/24/2018
10:37 AM
Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
01/24/2018
7:50 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/24/2018
7:40 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/22/2018
5:04 AM
Advanced Accelerator Applications S.A. (Subject)
Novartis (Filed by)
Form SC TO-T/A
View Filing
01/19/2018
4:04 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/12/2018
5:12 AM
Advanced Accelerator Applications S.A. (Subject)
Novartis (Filed by)
Form SC TO-T/A
View Filing
01/11/2018
9:08 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/21/2017
3:41 PM
Advanced Accelerator Applications S.A. (Subject)
Novartis (Filed by)
Form SC TO-T/A
View Filing
12/20/2017
11:57 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/19/2017
4:02 PM
ADURO BIOTECH, INC. (Subject)
Novartis (Filed by)
Form SC 13G/A
View Filing
12/15/2017
4:44 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
11:19 AM
Intellia Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/07/2017
5:03 AM
Advanced Accelerator Applications S.A. (Subject)
Novartis (Filed by)
Form SC TO-T
View Filing
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel